| Segment Expenses |
As a single reportable segment
entity, the Company’s segment performance measure is net income / (loss) attributable to shareholders. Significant segment expenses, as provided to the CODM, are presented below:
| |
|
Three Months Ended
June 30,
|
|
|
Six Months Ended
June 30,
|
|
| |
|
2026
|
|
|
2025
|
|
|
2026
|
|
|
2025
|
|
|
Segment expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Salaries and Benefits
|
|
$
|
3,377,524
|
|
|
$
|
2,857,617
|
|
|
$ |
6,775,882 |
|
|
$ |
6,686,838 |
|
|
Professional fees
|
|
|
1,111,476
|
|
|
|
1,278,581
|
|
|
|
2,018,160 |
|
|
|
2,405,627 |
|
|
General administrative expenses
|
|
|
309,370
|
|
|
|
387,897
|
|
|
|
651,869 |
|
|
|
732,251 |
|
|
Clinical development expenses
|
|
|
1,084,716
|
|
|
|
2,017,145
|
|
|
|
2,353,900 |
|
|
|
2,455,049 |
|
|
Other development expenses
|
|
|
613,648
|
|
|
|
1,082,111
|
|
|
|
1,218,010 |
|
|
|
4,449,344 |
|
|
Total operating and segment expenses
|
|
$
|
6,496,734
|
|
|
$ |
7,623,351 |
|
|
$ |
13,017,821 |
|
|
$ |
16,729,109 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest income
|
|
|
125,405
|
|
|
|
333,624
|
|
|
|
312,219 |
|
|
|
711,473 |
|
|
Interest expense
|
|
|
(3,379,246
|
)
|
|
|
(2,144,481
|
)
|
|
|
(4,394,029 |
) |
|
|
(3,075,359 |
) |
|
Benefit from income taxes
|
|
|
-
|
|
|
|
-
|
|
|
|
- |
|
|
|
1,169,820 |
|
|
Segment and consolidated net loss
|
|
$
|
(9,750,575
|
)
|
|
$
|
(9,434,208
|
)
|
|
$ |
(17,099,631 |
) |
|
$ |
(17,923,175 |
) |
|